Literature DB >> 21547489

Akt as a victim, villain and potential hero in Parkinson's disease pathophysiology and treatment.

Lloyd A Greene1, Oren Levy, Cristina Malagelada.   

Abstract

There are two major purposes of this essay. The first is to summarize existing evidence that irrespective of the initiating causes, neuron death and degeneration in Parkinson's disease (PD) are due to the common feature of failure of signaling by Akt, a kinase involved in neuron survival and maintenance of synaptic contacts. The second is to consider possible means by which such a failure of Akt signaling might be benignly prevented or reversed in neurons affected by PD, so as to treat PD symptoms, block disease progression, and potentially, promote recovery.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21547489      PMCID: PMC3678379          DOI: 10.1007/s10571-011-9671-8

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  92 in total

1.  Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease.

Authors:  Vincent Ries; Claire Henchcliffe; Tatyana Kareva; Margarita Rzhetskaya; Ross Bland; Matthew J During; Nikolai Kholodilov; Robert E Burke
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-20       Impact factor: 11.205

Review 2.  Inhibition of mitogen-activated protein kinase and stimulation of Akt kinase signaling pathways: Two approaches with therapeutic potential in the treatment of neurodegenerative disease.

Authors:  Robert E Burke
Journal:  Pharmacol Ther       Date:  2007-02-27       Impact factor: 12.310

Review 3.  Involvement of Akt in neurite outgrowth.

Authors:  Danielle E Read; Adrienne M Gorman
Journal:  Cell Mol Life Sci       Date:  2009-06-06       Impact factor: 9.261

4.  Striatal Akt/GSK3 signaling pathway in the development of L-Dopa-induced dyskinesias in MPTP monkeys.

Authors:  Marc Morissette; Pershia Samadi; Abdallah Hadj Tahar; Nancy Bélanger; Thérèse Di Paolo
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2009-12-16       Impact factor: 5.067

5.  Bioactivity of AAV2-neurturin gene therapy (CERE-120): differences between Parkinson's disease and nonhuman primate brains.

Authors:  Raymond T Bartus; Christopher D Herzog; Yaping Chu; Alistair Wilson; Lamar Brown; Joao Siffert; Eugene M Johnson; C Warren Olanow; Elliott J Mufson; Jeffrey H Kordower
Journal:  Mov Disord       Date:  2010-11-18       Impact factor: 10.338

6.  Alpha-synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells.

Authors:  Xiangmin Peng; Xiangmin M Peng; Roya Tehranian; Paula Dietrich; Leonidas Stefanis; Ruth G Perez
Journal:  J Cell Sci       Date:  2005-07-19       Impact factor: 5.285

7.  Caffeine activates the PI3K/Akt pathway and prevents apoptotic cell death in a Parkinson's disease model of SH-SY5Y cells.

Authors:  Kazuhiro Nakaso; Satoru Ito; Kenji Nakashima
Journal:  Neurosci Lett       Date:  2007-12-23       Impact factor: 3.046

8.  Glucagon-like peptide-1 (GLP-1) protects against methylglyoxal-induced PC12 cell apoptosis through the PI3K/Akt/mTOR/GCLc/redox signaling pathway.

Authors:  R Kimura; M Okouchi; H Fujioka; A Ichiyanagi; F Ryuge; T Mizuno; K Imaeda; N Okayama; Y Kamiya; K Asai; T Joh
Journal:  Neuroscience       Date:  2009-05-20       Impact factor: 3.590

Review 9.  α-Synuclein and dopamine at the crossroads of Parkinson's disease.

Authors:  Lara Lourenço Venda; Stephanie J Cragg; Vladimir L Buchman; Richard Wade-Martins
Journal:  Trends Neurosci       Date:  2010-10-18       Impact factor: 13.837

10.  Oxidative modifications, mitochondrial dysfunction, and impaired protein degradation in Parkinson's disease: how neurons are lost in the Bermuda triangle.

Authors:  Kristen A Malkus; Elpida Tsika; Harry Ischiropoulos
Journal:  Mol Neurodegener       Date:  2009-06-05       Impact factor: 14.195

View more
  29 in total

1.  Akt Phosphorylates NQO1 and Triggers its Degradation, Abolishing Its Antioxidative Activities in Parkinson's Disease.

Authors:  Shilin Luo; Seong Su Kang; Zhi-Hao Wang; Xia Liu; Julia X Day; Zhiping Wu; Junmin Peng; Daxiong Xiang; Wolfdieter Springer; Keqiang Ye
Journal:  J Neurosci       Date:  2019-07-29       Impact factor: 6.167

2.  ER Stress, CREB, and Memory: A Tangled Emerging Link in Disease.

Authors:  Nilkantha Sen
Journal:  Neuroscientist       Date:  2018-11-26       Impact factor: 7.519

3.  Tetramethylpyrazine Analogue CXC195 Protects Against Dopaminergic Neuronal Apoptosis via Activation of PI3K/Akt/GSK3β Signaling Pathway in 6-OHDA-Induced Parkinson's Disease Mice.

Authors:  Lin Chen; Li Cheng; Xinbing Wei; Zheng Yuan; Yanmei Wu; Shuaishuai Wang; Zhiping Ren; Xinyong Liu; Huiqing Liu
Journal:  Neurochem Res       Date:  2016-12-22       Impact factor: 3.996

4.  Neurotrophic effects of serum- and glucocorticoid-inducible kinase on adult murine mesencephalic dopamine neurons.

Authors:  Xiqun Chen; Patricia Tagliaferro; Tatyana Kareva; Olga Yarygina; Nikolai Kholodilov; Robert E Burke
Journal:  J Neurosci       Date:  2012-08-15       Impact factor: 6.167

5.  Age and α-synuclein expression interact to reveal a dependence of dopaminergic axons on endogenous Akt/PKB signaling.

Authors:  Sang Ryong Kim; Vincent Ries; Hsiao-Chun Cheng; Tatyana Kareva; Tinmarla F Oo; W Haung Yu; Karen Duff; Nikolai Kholodilov; Robert E Burke
Journal:  Neurobiol Dis       Date:  2011-07-18       Impact factor: 5.996

Review 6.  Mitochondria, OxPhos, and neurodegeneration: cells are not just running out of gas.

Authors:  Estela Area-Gomez; Cristina Guardia-Laguarta; Eric A Schon; Serge Przedborski
Journal:  J Clin Invest       Date:  2019-01-02       Impact factor: 14.808

7.  Clustering of Alzheimer's and Parkinson's disease based on genetic burden of shared molecular mechanisms.

Authors:  Mohammad Asif Emon; Ashley Heinson; Ping Wu; Daniel Domingo-Fernández; Meemansa Sood; Henri Vrooman; Jean-Christophe Corvol; Phil Scordis; Martin Hofmann-Apitius; Holger Fröhlich
Journal:  Sci Rep       Date:  2020-11-05       Impact factor: 4.379

8.  Agmatine Protects Against 6-OHDA-Induced Apoptosis, and ERK and Akt/GSK Disruption in SH-SY5Y Cells.

Authors:  Esmat Amiri; Rasoul Ghasemi; Maryam Moosavi
Journal:  Cell Mol Neurobiol       Date:  2015-09-07       Impact factor: 5.046

9.  Regulation of AKT/AMPK signaling, autophagy and mitigation of apoptosis in Rutin-pretreated SH-SY5Y cells exposed to MPP.

Authors:  Adaze Bijou Enogieru; William Haylett; Donavon Charles Hiss; Okobi Eko Ekpo
Journal:  Metab Brain Dis       Date:  2020-11-04       Impact factor: 3.584

Review 10.  Recent Insights into the Interplay of Alpha-Synuclein and Sphingolipid Signaling in Parkinson's Disease.

Authors:  Joanna A Motyl; Joanna B Strosznajder; Agnieszka Wencel; Robert P Strosznajder
Journal:  Int J Mol Sci       Date:  2021-06-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.